Byron D. Ford, Ph.D is a Professor in the Department of Neurobiology and the Director of the Neuroprotection, Neurorepair and Stroke Program at the Morehouse School of Medicine in Atlanta, GA. Dr. Ford is an expert in the cellular and molecular events associated with stroke and acute brain injuries. In 2005 he published a groundbreaking research article showing that neureglin-1 can protect neurons and reduce inflammation in an animal model of stroke. Since then, Dr. Ford’s work on developing better methods for treating and diagnosing stroke has been published in several peer-reviewed journals. He has produced a number of patents. As a principal investigator in the NINDS CounterACT Program, Dr. Ford is also developing neuregulin-1 as a countermeasure to prevent brain injury following chemical threat agents. Dr. Ford received his Ph.D. from Meharry Medical College and completed postdoctoral studies at Harvard Medical School and the NIH. Dr. Ford has received numerous honors and recent recognition by the Southeast BIO Investor Forum. He is a member of the AAAS and sits on the Basic Sciences Council of the American Heart Association.
Last Modified September 27, 2012